Sevelamer hydrochloride
Sevelamer Hydrochloride is a prescription drug that helps lower phosphate levels in the blood for patients with chronic kidney disease. Available as oral tablets in 400mg and 800mg doses, it's made by Aurobindo Pharma Limited. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[ "009:10" ] |
| contactPoint |
{ "fn": "Division of Drug Information", "@type": "vcard:Contact", "hasEmail": "mailto:druginfo@fda.hhs.gov" } |
| description | Sevelamer Hydrochloride is a prescription drug that helps lower phosphate levels in the blood for patients with chronic kidney disease. Available as oral tablets in 400mg and 800mg doses, it's made by Aurobindo Pharma Limited. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[ { "@type": "dcat:Distribution", "title": "Sevelamer hydrochloride", "mediaType": "text/html", "description": " Access the FDA dataset for Sevelamer hydrochloride — ANDA 213145 submitted by Mylan Institutional LLC ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213145" } ] |
| identifier | ANDA213145 |
| issued | 2016-09-16 |
| keyword |
[ "drug-manufacturers", "drug-safety", "health-care", "medications", "pharmaceuticals" ] |
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[ "009:002" ] |
| publisher |
{ "name": "U.S. Food and Drug Administration", "@type": "org:Organization" } |
| theme |
[ "FDA" ] |
| title | Sevelamer hydrochloride |
